A freeze of NIH funding threatens research into aging and Alzheimer’s at the UW School of Medicine. By David Marcinek, Jessica Young, Suman Jayadev, Thomas Grabowski and C. Dirk Keene / For The Herald ...

“The NIH decision to restrict access to key genomic and medical datasets hinders global cooperation at a time when coordinated action is needed”, said Anjee Davis (Fight Colorectal Cancer, Springfield ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with early-stage disease.

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Richard “Marcy” Price, a former Hunt Valley real estate office manager who won All-American lacrosse honors in 1962, died ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

“While there’s still a lot to learn, these findings show that regular intensity exercise, even at low intensity, could go a ...

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...